Latest News
February 24, 2025
Aptitude receives FDA Authorization for the Metrix® COVID/Flu test.
January 13, 2025
Aptitude's Metrix® platform is highlighted in GenomeWeb.
January 6, 2025
Aptitude Secures $10M+ to Accelerate Development of Point-of-Care and Over-the-Counter CT/NG/TV STI Test on Metrix® Platform.
December 5, 2024
Aptitude provided invited webinar by NERUCA: Surprising Insights From Your Urgent Care Payer Data, How a new type of molecular diagnostics enables better medicine and better margins.
March 21, 2024
Aptitude's Metrix® platform is highlighted in Nature.
January 3, 2024
Aptitude partners with Sekisui Diagnostics to expand distribution of Metrix® COVID-19 test.
October 1, 2023
Aptitude launches sale of Metrix® COVID-19 test on Amazon.com.
September 1, 2023
Aptitude launches ecommerce site for sale of Metrix® COVID-19 test.
July 24, 2023
Aptitude partners with Bill & Melinda Gates Foundation (BMGF) to accelerate the commercialization of the Metrix® Multiplex STI panel for Point-of-Care and Over-the-Counter use. This product will transform access to critical diagnostic information in the domestic market and in Low and Middle Income Countries.
April 20, 2023
Aptitude Receives up to $54 Million Partnership with BARDA to Develop Diagnostics for Point-of-Care and At-Home Use.
October 18, 2022
Aptitude received FDA Emergency Use Authorization for the Metrix® COVID-19 Test, the world's first saliva/swab based molecular test for at-home and over-the-counter use without physician supervision.
August 3, 2022
Aptitude submitted request to the FDA for Emergency Use Authorization seeking first saliva/swab based molecular over-the-counter COVID-19 test.
January 27, 2021
Aptitude has received multi-million dollar funding to develop its next-generation molecular diagnostics platform through regulatory approval.
December 21, 2020
Aptitude received California Clinical Laboratory Improvement Amendments (CLIA) license for high-complexity molecular testing.
July 10, 2020
Aptitude was admitted into the prestigious NIH RADx program to develop COVID-19 tests that are easier to use, easier to access, and more accurate.
Latest Events and Attendances
May 2025
Aptitude will present an invited talk at the Urgent Care Association National Convention in Dallas, TX.
March 2025
Aptitude will present an invited talk at the Urgent Care Connect Conference in Louisville, KY.
January 2025
Aptitude will attend JP Morgan Healthcare Conference, San Francisco, CA.
October 2025
Aptitude will attend HLTH in Las Vegas, NV.
September 2024
Aptitude will attend the HIDA Streamlining Healthcare Expo & Business Exchange in Dallas, TX.
September 2024
Aptitude will attend the Merchant Medicine Symposium in New Orleans, LA.
September 2024
Aptitude will attend the American Academy of Family Physicians FMX, Phoenix, AZ.
September 2024
Aptitude will attend the American Academy of Pediatrics National Conference and Exhibition in Orlando, FL.
August 2024
Aptitude will attend the Community Health Institute Conference and Exhibition in Atlanta, GA.
July 2024
Aptitude will attend the Urgent Care Association Assembly in Miami, FL.
July 2024
Aptitude will exhibit at the Association for Diagnostics & Laboratory Medicine in Chicago, IL.
June 2024
Aptitude will attend the National Association of Directors of Nursing Administration Conference in Kansas City, MO.
April 2024
Aptitude will attend the Urgent Care National Convention in Las Vegas, NV.
April 2024
Aptitude will attend the Southern California Community Healthcare Symposium in Los Angeles, CA.
February 2024
Aptitude will attend Urgent Care Connect in Austin, TX.
January 2024
Aptitude will attend JP Morgan Healthcare Conference, San Francisco, CA.
November 2023
Aptitude will present at the Research and Innovation Translation Partnerships in Point-of-Care Technologies Conference and Technology (POCTRN) Showcase, Bethesda, MD.
October 2023
Aptitude will give an invited presentation at Gates Grand Challenges 2023, Dakar Senegal.
October 2023
Aptitude will attend HLTH 2023 in Las Vegas, NV.
